The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Global Viscosupplementation Market Report By Product (Single Injection,Three Injection,Five Injection), By End-use Outlook (Hospitals,Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028
ID:VMR11213813
April 2021
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Viscosupplementation Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022-2028.
Viscosupplementation is a treatment procedure for osteoarthritis. Here a gel-like fluid called hyaluronic acid injected into the knee joint acts as a lubricant. This injection facilitates smooth movement of knee joints and reduces swelling or pain around the knee. Hyaluronic acid acts as a shock absorber for loads at the joint and improves knee function. Viscosupplementation does not reverse the arthritic process or re-grow cartilages and is highly effective if the arthritis is in its early stages. This treatment is considered for patients trying to delay getting surgery on the joint. It can be used to treat some instances of rheumatoid arthritis as well.
Market Dynamics
The increased preference for nonsurgical procedures for long-lasting pain relief and mobility restoration in osteoarthritis patients will be the few essential elements favoring this market's growth. The emergence of lifestyle-induced disorders and a significant rise in the demand for proper treatment and cure among people of all income groups will further propel market growth. High investments in the healthcare industry to enable easy access to available diagnosis and treatment options will boost the market growth. A rise in the number of specialized orthopedic clinics and ambulatory surgical centers will be a market booster. The lack of clinical evidence on viscosupplementation's effectiveness and safety continues to hamper this market's growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each segment in the global market of viscosupplementation.
Market Segmentation
This section of the viscosupplementation market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.
By Product
By End-use Outlook
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for Viscosupplementation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Viscosupplementation Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the viscosupplementation market include Sanofi, Anika Therapeutics, Inc., Seikagaku Corporation, Zimmer Holdings Inc., Bioventus, Ferring B.V., Lifecore Biomedical, LLC, and LG Life Sciences Ltd.S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Viscosupplementation is a treatment procedure for osteoarthritis. Here a gel-like fluid called hyaluronic acid injected into the knee joint acts as a lubricant. This injection facilitates smooth movement of knee joints and reduces swelling or pain around the knee. Hyaluronic acid acts as a shock absorber for loads at the joint and improves knee function. Viscosupplementation does not reverse the arthritic process or re-grow cartilages and is highly effective if the arthritis is in its early stages. This treatment is considered for patients trying to delay getting surgery on the joint. It can be used to treat some instances of rheumatoid arthritis as well.
Market Dynamics
The increased preference for nonsurgical procedures for long-lasting pain relief and mobility restoration in osteoarthritis patients will be the few essential elements favoring this market's growth. The emergence of lifestyle-induced disorders and a significant rise in the demand for proper treatment and cure among people of all income groups will further propel market growth. High investments in the healthcare industry to enable easy access to available diagnosis and treatment options will boost the market growth. A rise in the number of specialized orthopedic clinics and ambulatory surgical centers will be a market booster. The lack of clinical evidence on viscosupplementation's effectiveness and safety continues to hamper this market's growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each segment in the global market of viscosupplementation.
Market Segmentation
This section of the viscosupplementation market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.
By Product
- Single Injection
- Three Injection
- Five Injection
By End-use Outlook
- Hospitals
- Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for Viscosupplementation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Viscosupplementation Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the viscosupplementation market include Sanofi, Anika Therapeutics, Inc., Seikagaku Corporation, Zimmer Holdings Inc., Bioventus, Ferring B.V., Lifecore Biomedical, LLC, and LG Life Sciences Ltd.S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . VISCOSUPPLEMENTATION – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Product
3.7.2 By End Use
3.7.3 By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL VISCOSUPPLEMENTATION MARKET ANALYSIS BY PRODUCT
6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Single Injection Market by Regions
6.6 Three Injection Market by Regions
6.5 Five Injection Market by Regions
7 . GLOBAL VISCOSUPPLEMENTATION MARKET ANALYSIS BY END USE
7.1 Overview by End Use
7.2 Historical and Forecast Data
7.3 Analysis by End Use
7.4 Hospitals Market by Regions
7.5 Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) Market by Regions
8 . GLOBAL VISCOSUPPLEMENTATION MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America
8.3.1. Overview, Historic and Forecast Data
8.3.2. North America By Segment
8.3.3. North America By Country
8.3.4. United State
8.3.5. Canada
8.3.6. Mexico
8.4. Europe
8.4.1. Overview, Historic and Forecast Data
8.4.2. Europe by Segment
8.4.3. Europe by Country
8.4.4. United Kingdom
8.4.5. France
8.4.6. Germany
8.4.7. Italy
8.4.8. Russia
8.4.9. Rest Of Europe
8.5. Asia Pacific
8.5.1. Overview, Historic and Forecast Data
8.5.2. Asia Pacific by Segment
8.5.3. Asia Pacific by Country
8.5.4. China
8.5.5. India
8.5.6. Japan
8.5.7. South Korea
8.5.8. Australia
8.5.9. Rest Of Asia Pacific
8.6. Latin America
8.6.1. Overview, Historic and Forecast Data
8.6.2. Latin America by Segment
8.6.3. Latin America by Country
8.6.4. Brazil
8.6.5. Argentina
8.6.6. Peru
8.6.7. Chile
8.6.8. Rest of Latin America
8.7. Middle East & Africa
8.7.1. Overview, Historic and Forecast Data
8.7.2. Middle East & Africa by Segment
8.7.3. Middle East & Africa by Country
8.7.4. Saudi Arabia
8.7.5. UAE
8.7.6. Israel
8.7.7. South Africa
8.7.8. Rest Of Middle East And Africa
9 . COMPETITIVE LANDSCAPE OF THE VISCOSUPPLEMENTATION COMPANIES
9.1. Viscosupplementation Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10 . COMPANY PROFILES OF VISCOSUPPLEMENTATION INDUSTRY
10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Sanofi
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products
10.3.4. Recent Developments
10.4. Anika Therapeutics, Inc.
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products
10.4.4. Recent Developments
10.5. Seikagaku Corporation
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products
10.5.4. Recent Developments
10.6. Zimmer Holdings Inc.
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Products
10.6.4. Recent Developments
10.7. Bioventus
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Products
10.7.4. Recent Developments
10.8. Ferring B.V.
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Products
10.8.4. Recent Developments
10.9. Lifecore Biomedical, LLC
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Products
10.9.4. Recent Developments
10.10. LG Life Sciences Ltd.
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Products
10.10.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Product (USD MN)
- Single Injection Market by Geography (USD MN)
- Three Injection Market by Geography (USD MN)
- Five Injection Market by Geography (USD MN)
- Analysis Market by End Use (USD MN)
- Hospitals Market by Geography (USD MN)
- Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) Market by Geography (USD MN)
- Global Viscosupplementation Market by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
LIST OF FIGURES
- Research Scope of Viscosupplementation Report
- Market Research Process
- Market Research Methodology
- Global Viscosupplementation Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Product
- Market Attractiveness Analysis by End Use
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Segment Analysis 1 (USD MN)
- Single Injection Market by Geography (USD MN)
- Three Injection Market by Geography (USD MN)
- Five Injection Market by Geography (USD MN)
- Global Market Analysis by End Use (USD MN)
- Hospitals Market by Geography (USD MN)
- Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) Market by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Company Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
Healthcare
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments